BMY
Price
$44.86
Change
+$0.18 (+0.40%)
Updated
Apr 26, 6:59 PM EST
89 days until earnings call
OGN
Price
$18.55
Change
+$0.13 (+0.71%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
Ad is loading...

BMY vs OGN ᐉ Comparison: Which is Better to Invest?

Header iconBMY vs OGN Comparison
Open Charts BMY vs OGNBanner chart's image
Bristol-Myers Squibb
Price$44.86
Change+$0.18 (+0.40%)
Volume$7.3M
CapitalizationN/A
Organon & Co
Price$18.55
Change+$0.13 (+0.71%)
Volume$709.1K
CapitalizationN/A
View a ticker or compare two or three
BMY vs OGN Comparison Chart

Loading...

BMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMY vs. OGN commentary
Apr 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Hold and OGN is a Hold.

COMPARISON
Comparison
Apr 28, 2024
Stock price -- (BMY: $44.85 vs. OGN: $18.55)
Brand notoriety: BMY: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 133% vs. OGN: 97%
Market capitalization -- BMY: $109.66B vs. OGN: $4.73B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. OGN’s [@Pharmaceuticals: Major] market capitalization is $4.73B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green whileOGN’s FA Score has 2 green FA rating(s).

  • BMY’s FA Score: 1 green, 4 red.
  • OGN’s FA Score: 2 green, 3 red.
According to our system of comparison, OGN is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 4 TA indicator(s) are bullish while OGN’s TA Score has 7 bullish TA indicator(s).

  • BMY’s TA Score: 4 bullish, 6 bearish.
  • OGN’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, OGN is a better buy in the short-term than BMY.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -8.34% price change this week, while OGN (@Pharmaceuticals: Major) price change was +4.10% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.21%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +0.76%.

Reported Earning Dates

BMY is expected to report earnings on Jul 26, 2024.

OGN is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (+1.21% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
A.I.dvisor published
a Summary for BMY with price predictions.
OPEN
A.I.dvisor published
a Summary for OGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BMY($110B) has a higher market cap than OGN($4.73B). BMY has higher P/E ratio than OGN: BMY (13.73) vs OGN (4.64). OGN YTD gains are higher at: 30.612 vs. BMY (-11.576). BMY has higher annual earnings (EBITDA): 19.4B vs. OGN (1.44B). BMY has more cash in the bank: 12.3B vs. OGN (693M). OGN has less debt than BMY: OGN (8.76B) vs BMY (41.5B). BMY has higher revenues than OGN: BMY (45B) vs OGN (6.26B).
BMYOGNBMY / OGN
Capitalization110B4.73B2,326%
EBITDA19.4B1.44B1,351%
Gain YTD-11.57630.612-38%
P/E Ratio13.734.64296%
Revenue45B6.26B719%
Total Cash12.3B693M1,775%
Total Debt41.5B8.76B474%
FUNDAMENTALS RATINGS
BMY: Fundamental Ratings
BMY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMYOGN
RSI
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
51%
Bullish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 6 days ago
57%
Bullish Trend 4 days ago
67%
Declines
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 9 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
62%
Aroon
ODDS (%)
Bearish Trend 2 days ago
47%
Bullish Trend 2 days ago
49%
View a ticker or compare two or three
Ad is loading...
BMYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TNA35.330.95
+2.76%
Direxion Daily Small Cap Bull 3X ETF
HEWJ41.480.96
+2.37%
iShares Currency Hedged MSCI Japan ETF
BWET18.10-0.03
-0.16%
Breakwave Tanker Shipping ETF
VNSE31.90-0.07
-0.22%
Natixis Vaughan Nelson Select ETF
JDST4.04-0.07
-1.70%
Direxion Daily Jr Gld Mnrs Bear 2X ETF

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with JNJ. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
+0.34%
JNJ - BMY
39%
Loosely correlated
-0.46%
PFE - BMY
36%
Loosely correlated
+0.55%
BIIB - BMY
34%
Loosely correlated
+3.18%
GILD - BMY
33%
Loosely correlated
+0.23%
MRK - BMY
33%
Poorly correlated
+0.37%
More

OGN and

Correlation & Price change

A.I.dvisor tells us that OGN and PFE have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OGN and PFE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+0.71%
PFE - OGN
32%
Poorly correlated
+0.55%
GRFS - OGN
32%
Poorly correlated
+1.75%
AMRN - OGN
30%
Poorly correlated
+1.72%
JNJ - OGN
30%
Poorly correlated
-0.46%
BMY - OGN
29%
Poorly correlated
+0.34%
More